大葉大學圖書館 |

Biomarkers in cardiovascular disease[electronic resource] /

紀錄類型:	書目-電子資源 : Monograph/item
杜威分類號:	616.1
書名/作者:	Biomarkers in cardiovascular disease/ edited by Vinood B. Patel, Victor R. Preedy.
其他作者:	Patel, Vinood B.
出版者:	Dordrecht : : Springer Netherlands :, 2016.
面頁冊數:	xxix, 1329 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Oncology.
標題:	Pharmacology/Toxicology.
標題:	Cardiovascular system - Diseases
標題:	Biochemical markers.
標題:	Biomedicine.
標題:	Cancer Research.
ISBN:	9789400776784
ISBN:	9789400776777
內容註:	High-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation -- Mass Spectrometry-Based Lipidomics for Biomarker Research -- Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation -- Pentraxin 3 as Biomarker -- Isoprostanes as Biomarkers of Disease and Early Biological Effect -- Fetal Membranes: Potential Source of Preterm Birth Biomarkers -- 1-Hydroxypyrene as a Biomarker for Environmental Health -- Biomarkers of Necrosis and Myocardial Remodeling -- Serum Heat Shock Proteins as Novel Biomarker for Heart -- Failure and Cardiovascular Diseases -- Traditional and Proteomic Biomarkers of Autosomal Dominant -- Polycystic Kidney Disease (ADPKD) -- Biomarker for Amyotrophic Lateral Sclerosis -- Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control -- Biomarkers of Graft-Versus-Host Disease.
摘要、提要註:	On an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide. Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Cardiovascular Disease combines detailed information on different cardiovascular conditions and the concomitant application of conventional, new and emerging biomarkers. It covers the latest knowledge, trends and applications. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry.
電子資源:	http://dx.doi.org/10.1007/978-94-007-7678-4

Biomarkers in cardiovascular disease[electronic resource] /
Biomarkers in cardiovascular disease[electronic resource] /edited by Vinood B. Patel, Victor R. Preedy. - Dordrecht :Springer Netherlands :2016. - xxix, 1329 p. :ill. (some col.), digital ;24 cm. - Biomarkers in disease: methods, discoveries and applications. - Biomarkers in disease: methods, discoveries and applications..

High-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation -- Mass Spectrometry-Based Lipidomics for Biomarker Research -- Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation -- Pentraxin 3 as Biomarker -- Isoprostanes as Biomarkers of Disease and Early Biological Effect -- Fetal Membranes: Potential Source of Preterm Birth Biomarkers -- 1-Hydroxypyrene as a Biomarker for Environmental Health -- Biomarkers of Necrosis and Myocardial Remodeling -- Serum Heat Shock Proteins as Novel Biomarker for Heart -- Failure and Cardiovascular Diseases -- Traditional and Proteomic Biomarkers of Autosomal Dominant -- Polycystic Kidney Disease (ADPKD) -- Biomarker for Amyotrophic Lateral Sclerosis -- Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control -- Biomarkers of Graft-Versus-Host Disease.

On an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide. Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Cardiovascular Disease combines detailed information on different cardiovascular conditions and the concomitant application of conventional, new and emerging biomarkers. It covers the latest knowledge, trends and applications. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry.

ISBN: 9789400776784

Standard No.: 10.1007/978-94-007-7678-4doiSubjects--Topical Terms:

205017
Oncology.

LC Class. No.: RC669.9

Dewey Class. No.: 616.1

Biomarkers in cardiovascular disease[electronic resource] /
LDR:02787nmm a2200325 a 4500 001 466113
003 DE-He213
005 20160901165721.0
006 m d
007 cr nn 008maaau
008 170415s2016 ne s 0 eng d
020 $a 9789400776784 $q (electronic bk.)
020 $a 9789400776777 $q (paper)
024 7 $a 10.1007/978-94-007-7678-4 $2 doi
035 $a 978-94-007-7678-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC669.9
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.1 $2 23
090 $a RC669.9 $b .B615 2016
245 0 0 $a Biomarkers in cardiovascular disease $h [electronic resource] / $c edited by Vinood B. Patel, Victor R. Preedy.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2016.
300 $a xxix, 1329 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Biomarkers in disease: methods, discoveries and applications
505 0 $a High-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation -- Mass Spectrometry-Based Lipidomics for Biomarker Research -- Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation -- Pentraxin 3 as Biomarker -- Isoprostanes as Biomarkers of Disease and Early Biological Effect -- Fetal Membranes: Potential Source of Preterm Birth Biomarkers -- 1-Hydroxypyrene as a Biomarker for Environmental Health -- Biomarkers of Necrosis and Myocardial Remodeling -- Serum Heat Shock Proteins as Novel Biomarker for Heart -- Failure and Cardiovascular Diseases -- Traditional and Proteomic Biomarkers of Autosomal Dominant -- Polycystic Kidney Disease (ADPKD) -- Biomarker for Amyotrophic Lateral Sclerosis -- Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control -- Biomarkers of Graft-Versus-Host Disease.
520 $a On an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide. Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Cardiovascular Disease combines detailed information on different cardiovascular conditions and the concomitant application of conventional, new and emerging biomarkers. It covers the latest knowledge, trends and applications. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry.
650 2 4 $a Oncology. $3 205017
650 2 4 $a Pharmacology/Toxicology. $3 463455
650 0 $a Cardiovascular system $x Diseases $x Molecular aspects. $3 617289
650 0 $a Biochemical markers. $3 431086
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Cancer Research. $3 463530
700 1 $a Patel, Vinood B. $3 486667
700 1 $a Preedy, Victor R. $3 418895
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Biomarkers in disease: methods, discoveries and applications. $3 670714
856 4 0 $u http://dx.doi.org/10.1007/978-94-007-7678-4
950 $a Biomedical and Life Sciences (Springer-11642)